Formulation and evaluation of mucoadhesive microspheres of metronidazole
DOI:
https://doi.org/10.18231/j.joapr.2024.12.1.93.99Keywords:
Metronidazole, mucoadhesive microspheres, Chitosan, Sodium alginate, Sodium carboxymethyl cellulose, drug deliveryAbstract
Objective: Develop and evaluate mucoadhesive microspheres using Chitosan, Sodium alginate, and Sodium carboxymethyl cellulose (NaCMC) for sustained oral delivery of Metronidazole, aiming to improve bioavailability. Methods: Metronidazole-loaded microspheres were prepared via ionotropic gelation method with varying polymer ratios. Particle size, entrapment efficiency, swelling index, mucoadhesion (sheep mucosae), morphology (SEM), in-vitro wash-off test, drug release profile, and stability (6 months) were evaluated. Results: Chitosan content positively correlated with microsphere size. Entrapment efficiency ranged from 51.43% to 94.15%. Chitosan-based formulations, especially MTZ-7 (Chitosan:NaCMC, 3:1), displayed the highest mucoadhesion. SEM analysis revealed rough, spherical microspheres with a continuous polymeric coat. In-vitro wash-off test demonstrated prolonged residence time for Chitosan formulations. Sustained drug release was observed throughout the study, with MTZ-7 exhibiting the most desirable release profile. Stability studies showed no significant changes in drug release for selected formulations after 6 months. Conclusions: Chitosan-based microspheres, particularly MTZ-7, demonstrated superior mucoadhesive properties, sustained and controlled drug release, and desirable stability. These findings suggest the potential of Chitosan-based microspheres as a promising oral drug delivery system for Metronidazole, potentially addressing bioavailability concerns and improving therapeutic efficacy.
Downloads
References
Wagh RT, Jadhav SL, Banerjee SK, Gaikwad DD. Mucoadhesive Microsphere: A Review. International Journal of Pharmaceutical Excellence, 1(1), 26-44 (2014).
Carvalho FC, Bruschi ML, Evangelista RC, Gremio MP. Mucoadhesive drug delivery system. Brazilian Journal of Pharmaceutical Sciences, 46(1), 1-17 (2010).
Huang Y, Li X, Tong Y, Li J. Mucoadhesive microspheres of chitosan/carboxymethyl chitosan for oral delivery of tetracycline hydrochloride: Preparation, characterization and in vitro evaluation. Carbohydrate Polymers, 98(2), 1422-1430 (2013).
Kaur P, Kaur S, Singal G. Chitosan-based nanoparticles for targeted delivery of raloxifene: design, development, and characterization. Journal of Drug Delivery Science and Technology, 53, 101257 (2019).
Abdelrahman SH, Abdel-Aziz RE, Abdelbary AA, Eissa HS. Design and in vitro evaluation of mucoadhesive microspheres for nasal delivery of loratadine. Journal of Drug Delivery Science and Technology, 44, 74-83 (2018).
Learoyd TP, Burrows JL, French E, Seville PC. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. European Journal of Pharmaceutics and Biopharmaceutics, 68, 224-34 (2008).
Lynne W, John HC, John TF. Amoxycillin release from a floating dosage form based on alginates. International Journal of Pharmaceutics, 210 (1),45-49 (2000).
Joshi VC, Khan IA, Maged HM. Use of scanning electron microscopy in the authentication of botanicals. Pharmacopeial Forum, 34, 1075-1078 (2008).
Liu Z, Zhang Z, Huo M, Li J, He H. Mucoadhesive thiolated chitosan nanoparticles for oral delivery of insulin: In vitro and ex vivo evaluation. International Journal of Pharmaceutics, 520(1-2), 22-32 (2017).
Kumar P, Pandit, JK. Development and in vitro evaluation of chitosan-alginate based mucoadhesive microspheres for the sustained and targeted delivery of Metronidazole. International Journal of Pharmaceutics, 471(1-2), 221-230 (2014).
Feng S, Yu Y, Wang Y, Zhu D. Preparation and evaluation of pH-sensitive chitosan/hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles for oral delivery of Metronidazole. Colloids and Surfaces B: Biointerfaces, 144, 306-313 (2016).
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2019). ICH Q1A: Stability testing of new drug substances and products. https://www.ema.europa.eu/en/ich-q1a-r2-stability-testing-new-drug-substances-and-drug-products-scientific-guideline
Mathews BR. Regulatory aspects of stability testing in Europe. Drug Development Industrial Pharmacy, 25 (7), 831-856 (1999).
Published
How to Cite
Issue
Section
Copyright (c) 2024 Dheeraj D. Chechare, M. Siddaiah
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.